Summary: Apnimed Inc, a clinical-stage pharmaceutical company developing oral therapies for obstructive sleep apnea and other sleep disorders, will showcase findings from a recent clinical trial on obesity hypoventilation syndrome (OHS) at the European Respiratory Society (ERS) … [Read more...]